KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 189 filers reported holding KRYSTAL BIOTECH INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $742 | +118.2% | 6,400 | +120.7% | 0.00% | +200.0% |
| Q2 2023 | $340 | +9.0% | 2,900 | -25.6% | 0.00% | – |
| Q1 2023 | $312 | -3.7% | 3,900 | -4.9% | 0.00% | -100.0% |
| Q4 2022 | $324 | -99.9% | 4,100 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $285,000 | +5.9% | 4,100 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $269,000 | +3.9% | 4,100 | +5.1% | 0.00% | 0.0% |
| Q1 2022 | $259,000 | -4.8% | 3,900 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $272,000 | +34.0% | 3,900 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $203,000 | -23.4% | 3,900 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $265,000 | +178.9% | 3,900 | +69.6% | 0.00% | – |
| Q2 2020 | $95,000 | -4.0% | 2,300 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $99,000 | -22.0% | 2,300 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $127,000 | -19.6% | 2,300 | -50.0% | 0.00% | – |
| Q3 2019 | $158,000 | +71.7% | 4,600 | +100.0% | 0.00% | – |
| Q2 2019 | $92,000 | – | 2,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 771,250 | $53,949,000 | 4.15% |
| First Light Asset Management, LLC | 680,170 | $47,578,000 | 3.41% |
| ACT CAPITAL MANAGEMENT, LLC | 59,000 | $4,127,000 | 2.98% |
| S Squared Technology, LLC | 95,215 | $6,660,000 | 2.98% |
| Redmile Group, LLC | 1,820,898 | $127,372,000 | 2.90% |
| Soleus Capital Management, L.P. | 228,437 | $15,979,000 | 1.60% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 50,922 | $3,562,000 | 1.59% |
| Artal Group S.A. | 700,000 | $48,965,000 | 1.33% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 46,670 | $3,265,000 | 1.32% |
| Kynam Capital Management, LP | 34,816 | $2,435,000 | 1.30% |